Silihan lan utang jangka dawa perusahaan: Amphastar (AMPH)

Logo perusahaan publik Amphastar (AMPH)

The current market quotes for Amphastar Pharmaceuticals (AMPH) visualized below on GURU.Markets rely on the human capital of Amphastar Pharmaceuticals (AMPH), where technologists develop rare dosage forms and the indicator stands at 0.65. The business generates profit through pricing power over critical drugs with low demand elasticity, while the company strictly adheres to medical regulations regarding waste processing and the energy efficiency of its production sites.

AMPH Utang jangka dawa perusahaan Amphastar Pharmaceuticals (04.07.2022 - 29.10.2026)
Produk merek Amphastar Pharmaceuticals, Inc.

This indicator aggregates all credit obligations with a maturity of more than one year, capturing the dynamics of borrowed capital and its impact on financial stability. Analyzing the magnitude of long-term liabilities for Amphastar Pharmaceuticals (AMPH) allows for an assessment of the cost of scaling the production of inhalation drugs and generics, where a sharp upward trend may signal an increasing debt burden on operating profit.

Karo sapa Amphastar Pharmaceuticals saingan

Utang jangka dawa perusahaan haleon.com HLN|KVUE - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan VRNA (Verona Pharma PLC)|Jyong Biotech Corp (MENS) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Ligand Corp|AMRX (Amneal Pharmaceuticals) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan perrigo.com|Kewajiban jangka dawa perusahaan ALVO (Alvotech SA)|LQDA (Liquidia Corp) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Galapagos Genomics GLPG|ANI Pharmaceuticals Corp (ANIP) - Utang jangka dawa|MNKD: Kewajiban jangka dawa perusahaan|pacira.com - Gedhene kewajiban jangka dawa|SPRY: Utang jangka dawa perusahaan|Theravance Biopharma Inc - Silihan lan utang jangka dawa perusahaan|AQST (Aquestive Pharma) - Utang jangka dawa perusahaan|Utang jangka dawa scPharma SCPH|Utang jangka dawa perusahaan Tectonic Therapeutic, Inc. (TECX)|TNXP (tonixpharma.com) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan SXTC (China SXT Pharmaceuticals, Inc.)|Utang jangka dawa perusahaan Eupraxia Pharmaceuticals, Inc. EPRX|BHST - Utang jangka dawa perusahaan|Invizyne (EXOZ) - Kewajiban jangka dawa perusahaan|oramed.com (ORMP) - Utang jangka dawa perusahaan|Kewajiban jangka dawa ENTX (Entera Bio)|HYFT (MindWalk Holdings Inc.) - Utang jangka dawa perusahaan|ABVC: Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan CPIX|Utang jangka dawa perusahaan Quantum BioPharma Corp (QNTM)|Utang jangka dawa perusahaan FibroGen, Inc. FGEN|Gunggunge utang jangka dawa telomirpharma.com (TELO)|RANI: Kewajiban jangka dawa perusahaan|Synergy CHC Corp - Gedhene kewajiban jangka dawa|RLYB: Utang jangka dawa perusahaan|Lexaria Bioscience Corp. (LEXX) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Pulmatrix, Inc.|PTHL: Silihan lan utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan APM (Aptorum Group Limited)|LYRA (Lyra Therapeutics Inc.) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Impact BioMedical Inc IBO|TNFA (TNF Pharmaceuticals Inc.) - Kewajiban jangka dawa|cbdMD Corp - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan PRFX (painreform.com)|CYTO: Utang jangka dawa perusahaan|Lipella Pharmaceuticals Inc (LIPO) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Optinose|PIRS: Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Procaps Group S.A. (PROC)|Kewajiban jangka dawa perusahaan petrospharma.com PTPI|Utang jangka dawa perusahaan QLI (Qilian International Holding)|Utang jangka dawa perusahaan Acelyrin Inc. SLRN|TFF Pharma - Utang jangka dawa perusahaan